Growth Metrics

Jaguar Health (JAGX) Cost of Revenue (2016 - 2025)

Jaguar Health (JAGX) has disclosed Cost of Revenue for 11 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue fell 18.97% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Dec 2025, up 37.79% year-over-year, with the annual reading at $3.8 million for FY2025, 50.94% down from the prior year.
  • Cost of Revenue for Q4 2025 was $2.2 million at Jaguar Health, up from $2.0 million in the prior quarter.
  • The five-year high for Cost of Revenue was $7.0 million in Q4 2021, with the low at -$2.9 million in Q4 2023.
  • Average Cost of Revenue over 5 years is $1.3 million, with a median of $640500.0 recorded in 2021.
  • The sharpest move saw Cost of Revenue surged 386.28% in 2022, then crashed 684.24% in 2023.
  • Over 5 years, Cost of Revenue stood at $7.0 million in 2021, then crashed by 92.96% to $495000.0 in 2022, then plummeted by 684.24% to -$2.9 million in 2023, then soared by 193.88% to $2.7 million in 2024, then decreased by 18.97% to $2.2 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $2.2 million, $2.0 million, and $2.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.